Jump to content
Wikipedia The Free Encyclopedia

Angela Koehler

From Wikipedia, the free encyclopedia
American biochemist and academic
Angela Nicole Koehler
Alma materHarvard University
Reed College
Scientific career
InstitutionsCalifornia Institute of Technology
Harvard University
Broad Institute
Thesis Small molecule microarrays: A high-throughput tool for discovering protein-small molecule interactions  (2003)
Doctoral advisor Stuart Schreiber

Angela N. Koehler is an American biochemist who is the Karl Van Tassel (1925) Career Development Professor of Chemical Biology at the Broad Institute. Her research considers the development of chemical tools to understand transcriptional regulation, and the design of next-generation pharmaceuticals.

Early life and education

[edit ]

Koehler was an undergraduate student in biochemistry at Reed College.[1] She worked on structural studies of proteins that recognize nucleic acids, including transfer RNA and DNA.[2] She moved to Harvard University as a doctoral researcher, where she worked alongside Stuart Schreiber on strategies to understand the interactions between proteins and molecules.[citation needed ]

Research and career

[edit ]

Koehler joined the chemical biology program at the Broad Institute, where she was made group leader for chemical genetics.[when? ][citation needed ] Koehler develops time-sensitive chemical tools to understand the dynamics of transcriptional regulation. Before the work of Koehler it was understood that transcription factors were "undruggable", as their inherent structural disorder compromised the binding of small-molecule ligands.[3] Her research looks to develop small-molecule probes[4] that modify proteins, which can, in turn, tune gene expression.[2] [5]

Koehler is on the faculty at the Koch Institute for Integrative Cancer Research.[6] She has founded several companies, including Ligon Discovery, a drug discovery company focused on small-molecule microarrays, Kronos Bio,[7] [8] a cancer therapeutics accelerator and 76Bio,[9] a biotechnology company that looks to develop targeted protein degraders.

Awards and honors

[edit ]

Selected publications

[edit ]

References

[edit ]
  1. ^ alan. "Alumni News from Reed Magazine, March '13 | Chemistry News" . Retrieved 2022年10月15日.
  2. ^ a b "Angela Koehler, PhD | MIT Department of Biological Engineering". be.mit.edu. Retrieved 2022年10月15日.
  3. ^ Henley, Matthew J.; Koehler, Angela N. (September 2021). "Advances in targeting 'undruggable' transcription factors with small molecules". Nature Reviews. Drug Discovery. 20 (9): 669–688. doi:10.1038/s41573-021-00199-0. ISSN 1474-1784. PMID 34006959. S2CID 234780718.
  4. ^ "Angela Koehler". Broad Institute. 2019年01月23日. Retrieved 2022年10月15日.
  5. ^ "Angela Koehler (MIT) | Target 2035". www.target2035.net. Retrieved 2022年10月15日.
  6. ^ a b "Broad announces new Merkin Institute Fellows". Broad Institute. 2013年11月22日. Retrieved 2022年10月15日.
  7. ^ "Angela Koehler, Ph.D." Kronos Bio. Retrieved 2022年10月16日.
  8. ^ Ryan Cross (2018年11月05日). "Kronos Bio". C&EN Global Enterprise. 96 (44): 38–39. doi:10.1021/cen-09644-cover6 . ISSN 2474-7408. S2CID 239821660.
  9. ^ "Home - 76bio" . Retrieved 2022年10月15日.
  10. ^ "Angela Koehler: The Small Molecule World". GenomeWeb. 2012年12月03日. Retrieved 2022年10月15日.
  11. ^ "HBC Research Seminar October 2020". hbc.ku.edu. Retrieved 2022年10月15日.
  12. ^ "ONO PHARMA FOUNDATION". Grantmakers.io. Retrieved 2022年10月15日.
  13. ^ "Angela Koehler". www.nasonline.org. Retrieved 2022年10月15日.
  14. ^ "NSF Award Search: Award # 1845464 - CAREER: Reprogramming Transcriptional Regulation by Chemical Stabilization of Repressive Homodimers". www.nsf.gov. Retrieved 2022年10月15日.
  15. ^ "MIT School of Engineering | » Teaching Awards". Mit Engineering. Retrieved 2022年10月15日.

AltStyle によって変換されたページ (->オリジナル) /